{"id":"pulmicort-turbuhaler","safety":{"commonSideEffects":[{"rate":null,"effect":"Tremor"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nervousness"},{"rate":null,"effect":"Palpitations"},{"rate":null,"effect":"Muscle cramps"},{"rate":null,"effect":"Oral candidiasis"}]},"_chembl":{"chemblId":"CHEMBL1370","moleculeType":"Small molecule","molecularWeight":"430.54"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Budesonide exerts its anti-inflammatory effects by activating glucocorticoid receptors in the cytoplasm of airway cells, which translocate to the nucleus and modulate gene expression. This leads to decreased production of inflammatory mediators (cytokines, chemokines, adhesion molecules) and reduced recruitment of inflammatory cells to the airways. The Turbuhaler is a dry powder inhaler formulation that delivers the drug directly to the lungs for local action.","oneSentence":"Pulmicort (budesonide) is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:59.850Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma (maintenance and reliever therapy)"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT06860542","phase":"PHASE2","title":"Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2026-02-10","conditions":"Pneumonitis, Immune-related Adverse Event","enrollment":94},{"nctId":"NCT05309590","phase":"","title":"Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2014-05","conditions":"Eosinophilic Esophagitis","enrollment":50},{"nctId":"NCT07267130","phase":"PHASE1","title":"A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.","startDate":"2025-11-25","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":57},{"nctId":"NCT05202262","phase":"PHASE3","title":"A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-01-12","conditions":"Asthma","enrollment":645},{"nctId":"NCT04545866","phase":"PHASE3","title":"The Budesonide in Babies (BiB) Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"NICHD Neonatal Research Network","startDate":"2021-04-01","conditions":"Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome, Prematurity; Extreme","enrollment":642},{"nctId":"NCT00584636","phase":"PHASE4","title":"Pulmicort Respules on Relapse Rates After Treatment in the ED","status":"WITHDRAWN","sponsor":"Phoenix Children's Hospital","startDate":"2007-10","conditions":"Asthma","enrollment":""},{"nctId":"NCT06429475","phase":"PHASE3","title":"Anti-Inflammatory Reliever South Africa","status":"RECRUITING","sponsor":"University of KwaZulu","startDate":"2024-06-06","conditions":"Asthma","enrollment":1038},{"nctId":"NCT04193878","phase":"PHASE3","title":"ARrest RESpiraTory Failure From PNEUMONIA","status":"TERMINATED","sponsor":"Stanford University","startDate":"2020-06-01","conditions":"Pneumonia, Hypoxemia, Acute Respiratory Failure","enrollment":465},{"nctId":"NCT04374474","phase":"PHASE4","title":"Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)","status":"WITHDRAWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2021-01-10","conditions":"Olfactory Disorder","enrollment":""},{"nctId":"NCT06272370","phase":"PHASE4","title":"Individualizing Treatment for Asthma in Primary Care","status":"COMPLETED","sponsor":"DARTNet Institute","startDate":"2024-02-01","conditions":"Asthma, Bronchial Diseases, Respiratory Tract Infections","enrollment":103},{"nctId":"NCT02907593","phase":"PHASE1, PHASE2","title":"Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial","status":"TERMINATED","sponsor":"Cynthia McEvoy","startDate":"2016-09","conditions":"Bronchopulmonary Dysplasia (BPD)","enrollment":25},{"nctId":"NCT06837051","phase":"NA","title":"The Effect of Modified Olfactory Training on Postoperative Olfactory Dysfunction in Patients With CRS","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-03-14","conditions":"Olfactory Dysfunction, Chronic Rhinosinusitis","enrollment":213},{"nctId":"NCT06595121","phase":"PHASE1","title":"Bioequivalence of IMP 08P1707F0 Relative to Pulmicort® (1.0 Mg/2 Ml Suspension)","status":"COMPLETED","sponsor":"Unither Pharmaceuticals, France","startDate":"2024-08-13","conditions":"Healthy","enrollment":24},{"nctId":"NCT06535087","phase":"","title":"The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life","status":"RECRUITING","sponsor":"Wenjing Zhou","startDate":"2024-07-20","conditions":"Pediatric Asthma, Rhinitis, Allergic, Quality of Life","enrollment":600},{"nctId":"NCT03615742","phase":"PHASE4","title":"Diesel Exhaust Induces Glucocorticoid Resistance","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2018-12-01","conditions":"Exposure to Pollution, Glucocorticoid Resistance","enrollment":30},{"nctId":"NCT00442117","phase":"PHASE3","title":"A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-06","conditions":"Asthma","enrollment":180},{"nctId":"NCT02455687","phase":"PHASE3","title":"Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2015-06","conditions":"Bronchial Asthma","enrollment":240},{"nctId":"NCT04705727","phase":"PHASE3","title":"Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation","status":"TERMINATED","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2021-08-23","conditions":"Asthma in Children","enrollment":102},{"nctId":"NCT05904002","phase":"NA","title":"Effect of Incentive Spirometery on Asthmatic Pregnant Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-09-20","conditions":"Asthmatic, Pregnant With Complication","enrollment":60},{"nctId":"NCT03275415","phase":"PHASE4","title":"Intratracheal Budesonide/Surfactant Prevents BPD","status":"COMPLETED","sponsor":"Taipei Medical University","startDate":"2019-07-01","conditions":"Respiratory Distress Syndrome, Bronchopulmonary Dysplasia","enrollment":310},{"nctId":"NCT03034005","phase":"PHASE4","title":"The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma","status":"COMPLETED","sponsor":"Bispebjerg Hospital","startDate":"2017-03-27","conditions":"Asthma","enrollment":60},{"nctId":"NCT05148312","phase":"PHASE1","title":"Single-dose AQ001S PK Study in Healthy Volunteers","status":"COMPLETED","sponsor":"Aquilon Pharmaceuticals S.A.","startDate":"2021-11-12","conditions":"Pharmacokinetics","enrollment":29},{"nctId":"NCT05364385","phase":"PHASE4","title":"Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease","status":"UNKNOWN","sponsor":"University of Arizona","startDate":"2019-12-02","conditions":"Infant, Extremely Premature, Acute Lung Injury, Chronic Lung Disease of Prematurity","enrollment":25},{"nctId":"NCT03691961","phase":"NA","title":"Corticosteroids/β2-agonists in Hair in Asthmatic Patients (CorticHair)","status":"UNKNOWN","sponsor":"Hopital Foch","startDate":"2018-09-20","conditions":"Asthma","enrollment":24},{"nctId":"NCT04215848","phase":"PHASE3","title":"As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period","status":"COMPLETED","sponsor":"Hat Yai Medical Education Center","startDate":"2020-04-01","conditions":"Asthma","enrollment":31},{"nctId":"NCT05474924","phase":"PHASE4","title":"The Role of Budesonide Intrapolyp Injection in CRSwNP","status":"UNKNOWN","sponsor":"Kafrelsheikh University","startDate":"2022-08-01","conditions":"CRS, Polyp, Nasal","enrollment":90},{"nctId":"NCT04064684","phase":"PHASE2","title":"Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-02-04","conditions":"Acute Respiratory Distress Syndrome","enrollment":2},{"nctId":"NCT04476628","phase":"EARLY_PHASE1","title":"Efficacy of Budesonide Via Delayed Release vs Immediate Release","status":"WITHDRAWN","sponsor":"St. Paul's Hospital, Canada","startDate":"2021-02-01","conditions":"Chronic Rhinosinusitis (Diagnosis)","enrollment":""},{"nctId":"NCT01484691","phase":"NA","title":"Role of microRNAs in T Cell-Driven Inflammation in Asthma","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2012-01","conditions":"Asthma","enrollment":55},{"nctId":"NCT05378022","phase":"NA","title":"Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2020-12-21","conditions":"Acute Respiratory Tract Infections","enrollment":70},{"nctId":"NCT04848662","phase":"PHASE1","title":"To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years.","status":"COMPLETED","sponsor":"Bond Avillion 2 Development LP","startDate":"2021-05-06","conditions":"Asthma","enrollment":12},{"nctId":"NCT05325489","phase":"PHASE3","title":"Comparison of Nebulized Budesonide and Intranasal Budesonide Spray in Children With Adenotonsillar Hypertrophy","status":"UNKNOWN","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2022-04","conditions":"Snoring, Mouth Breathing","enrollment":100},{"nctId":"NCT04078126","phase":"PHASE3","title":"Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2019-09-10","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":35},{"nctId":"NCT05164692","phase":"NA","title":"Effects of Nasal-spraying LiveSpo Navax in Treatment of Acute Respiratory Infections in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2020-08-29","conditions":"Acute Respiratory Tract Infections","enrollment":100},{"nctId":"NCT05152355","phase":"PHASE4","title":"Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients","status":"COMPLETED","sponsor":"Intech Biopharm Ltd.","startDate":"2019-04-22","conditions":"Asthma","enrollment":270},{"nctId":"NCT01070888","phase":"PHASE4","title":"Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma","status":"TERMINATED","sponsor":"Boston Children's Hospital","startDate":"2010-02","conditions":"Exercise Induced Asthma","enrollment":6},{"nctId":"NCT03219866","phase":"PHASE4","title":"Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2017-10-03","conditions":"COPD, COPD Exacerbation","enrollment":40},{"nctId":"NCT03197818","phase":"PHASE3","title":"Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2016-12-14","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":990},{"nctId":"NCT04416399","phase":"PHASE2","title":"STerOids in COVID-19 Study","status":"TERMINATED","sponsor":"University of Oxford","startDate":"2020-07-16","conditions":"Coronavirus Infection","enrollment":146},{"nctId":"NCT01253473","phase":"PHASE4","title":"Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"National Jewish Health","startDate":"2012-04","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":46},{"nctId":"NCT02497001","phase":"PHASE3","title":"A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)","status":"COMPLETED","sponsor":"Pearl Therapeutics, Inc.","startDate":"2015-08-10","conditions":"COPD","enrollment":1902},{"nctId":"NCT01787097","phase":"PHASE4","title":"Effect of Symbicort ® on GR in Sputum in COPD","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2013-01","conditions":"Chronic Obstructive Lung Disease","enrollment":31},{"nctId":"NCT01520688","phase":"PHASE4","title":"Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth","status":"COMPLETED","sponsor":"West Penn Allegheny Health System","startDate":"2012-02","conditions":"Asthma","enrollment":32},{"nctId":"NCT00413387","phase":"PHASE3","title":"Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2004-09","conditions":"Bronchial Asthma","enrollment":219},{"nctId":"NCT02991859","phase":"PHASE2","title":"Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-02-09","conditions":"Asthma","enrollment":56},{"nctId":"NCT00388739","phase":"NA","title":"Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2006-11-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT03262012","phase":"PHASE3","title":"Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®","status":"COMPLETED","sponsor":"Pearl Therapeutics, Inc.","startDate":"2016-08-09","conditions":"COPD","enrollment":416},{"nctId":"NCT02019758","phase":"PHASE4","title":"Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-01-01","conditions":"Eosinophilic Esophagitis","enrollment":129},{"nctId":"NCT02833480","phase":"PHASE2","title":"A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2015-02","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":69},{"nctId":"NCT04267042","phase":"EARLY_PHASE1","title":"Comparing Budesonide Via MAD or INSI Prospective Cohort Study","status":"UNKNOWN","sponsor":"St. Paul's Hospital, Canada","startDate":"2020-02-03","conditions":"Chronic Rhinosinusitis With Nasal Polyps, Allergic Fungal Sinusitis","enrollment":60},{"nctId":"NCT01978678","phase":"","title":"Does Asthma Phenotype Have Impact on Disease Control","status":"COMPLETED","sponsor":"Bispebjerg Hospital","startDate":"2012-11","conditions":"Asthma","enrollment":80},{"nctId":"NCT02224157","phase":"PHASE3","title":"A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-11-28","conditions":"Asthma","enrollment":4215},{"nctId":"NCT02149199","phase":"PHASE3","title":"A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-07-07","conditions":"Asthma","enrollment":3850},{"nctId":"NCT03421730","phase":"PHASE1","title":"A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild Asthma","status":"COMPLETED","sponsor":"Vectura Limited","startDate":"2017-12-18","conditions":"Wheezing, Reactive Airway Disease, Mild Asthma","enrollment":17},{"nctId":"NCT03934333","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2019-05-16","conditions":"Relative Bioavailability","enrollment":11},{"nctId":"NCT00159263","phase":"NA","title":"Effect of Symbicort on GR Localisation in Asthma","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2004-11","conditions":"Asthma","enrollment":10},{"nctId":"NCT02766608","phase":"PHASE3","title":"Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD","status":"COMPLETED","sponsor":"Pearl Therapeutics, Inc.","startDate":"2016-05-31","conditions":"Chronic Obstructive Pulmonary Disorder","enrollment":2389},{"nctId":"NCT04097613","phase":"EARLY_PHASE1","title":"Betadine Rinses for Chronic Rhinosinusitis Prospective Cohort Study","status":"COMPLETED","sponsor":"St. Paul's Hospital, Canada","startDate":"2017-07-28","conditions":"Chronic Rhinosinusitis (Diagnosis)","enrollment":29},{"nctId":"NCT00661973","phase":"PHASE4","title":"Inhaled Corticosteroids on Airway Smooth Muscle in Asthma","status":"WITHDRAWN","sponsor":"Imperial College London","startDate":"2008-04","conditions":"Asthma","enrollment":""},{"nctId":"NCT03521063","phase":"PHASE4","title":"Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.","status":"UNKNOWN","sponsor":"Hospital Central \"Dr. Ignacio Morones Prieto\"","startDate":"2018-01-01","conditions":"Bronchopulmonary Dysplasia, Infant,Premature, Respiratory Distress Syndrome","enrollment":108},{"nctId":"NCT00291408","phase":"PHASE4","title":"Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD","status":"WITHDRAWN","sponsor":"Imperial College London","startDate":"2006-04","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Age Matched Healthy Volunteers (Non-smokers)","enrollment":""},{"nctId":"NCT04032834","phase":"PHASE1","title":"A Comparison of VR647 and Conventionally Nebulized Budesonide in Healthy Volunteers and Adult Asthma Subjects","status":"COMPLETED","sponsor":"Vectura Limited","startDate":"2017-02-20","conditions":"Asthma","enrollment":34},{"nctId":"NCT03369847","phase":"PHASE4","title":"Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge","status":"COMPLETED","sponsor":"New York City Health and Hospitals Corporation","startDate":"2017-09-10","conditions":"Asthma, Pediatric ALL","enrollment":43},{"nctId":"NCT04019106","phase":"PHASE1, PHASE2","title":"Budesonide With Intratracheal Surfactants in Extremely Preterm Infants","status":"UNKNOWN","sponsor":"University of Manitoba","startDate":"2019-10-15","conditions":"Bronchopulmonary Dysplasia, Respiratory Distress Syndrome in Premature Infant","enrollment":30},{"nctId":"NCT01415518","phase":"PHASE4","title":"Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2011-09-01","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":581},{"nctId":"NCT03175926","phase":"NA","title":"Description of the Ability to Learn How to Handle Inhaler Devices in Asthma","status":"WITHDRAWN","sponsor":"University Hospital, Bordeaux","startDate":"2017-12-01","conditions":"Asthma","enrollment":""},{"nctId":"NCT02446418","phase":"PHASE3","title":"A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-07-09","conditions":"Asthma","enrollment":423},{"nctId":"NCT02604173","phase":"PHASE3","title":"Altitude Sickness Prevention and Efficacy of Comparative Treatments","status":"COMPLETED","sponsor":"Stanford University","startDate":"2016-08","conditions":"Acute Mountain Sickness","enrollment":103},{"nctId":"NCT03687515","phase":"PHASE3","title":"Efficacy and Safety of Budesonide Inhalation Suspension for the Treatment of Chronic Rhinosinusitis With Polyposis.","status":"COMPLETED","sponsor":"Beijing Tongren Hospital","startDate":"2015-01-01","conditions":"Chronic Rhinosinusitis With Polyposis","enrollment":91},{"nctId":"NCT01895075","phase":"PHASE2","title":"Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study","status":"WITHDRAWN","sponsor":"Dr. Michael Dunn","startDate":"2019-01-01","conditions":"Bronchopulmonary Dysplasia","enrollment":""},{"nctId":"NCT02425813","phase":"PHASE2","title":"Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2015-10","conditions":"Acute Graft Versus Host Disease, Intestinal Graft Versus Host Disease","enrollment":""},{"nctId":"NCT03563001","phase":"PHASE4","title":"Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO)","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2018-06-20","conditions":"Pulmonary Disease, Chronic Obstructive, Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome, Small Airway Disease","enrollment":80},{"nctId":"NCT00675584","phase":"PHASE3","title":"CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2008-08","conditions":"Asthma","enrollment":278},{"nctId":"NCT03551197","phase":"PHASE4","title":"Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"Zhujiang Hospital","startDate":"2018-06-13","conditions":"Pulmonary Disease, Chronic Obstructive, Exercise, Lung Function Decreased","enrollment":50},{"nctId":"NCT01197612","phase":"PHASE3","title":"Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2010-09","conditions":"Chronic Sinusitis, Polyposis","enrollment":23},{"nctId":"NCT00716963","phase":"PHASE4","title":"Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2008-07","conditions":"Mild Intermittent Asthma","enrollment":7},{"nctId":"NCT02194062","phase":"NA","title":"Comparison of Nasal Steroids After FESS in CRSwNP","status":"COMPLETED","sponsor":"Yale University","startDate":"2015-01","conditions":"Sinusitis, Nasal Polyps","enrollment":32},{"nctId":"NCT02157935","phase":"PHASE3","title":"Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-06-27","conditions":"COPD Patients","enrollment":2026},{"nctId":"NCT02233803","phase":"PHASE4","title":"A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-11-14","conditions":"Asthma","enrollment":239},{"nctId":"NCT01218399","phase":"NA","title":"Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-09","conditions":"Asthma","enrollment":10},{"nctId":"NCT02357277","phase":"PHASE4","title":"The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2015-03","conditions":"Osteoporosis","enrollment":""},{"nctId":"NCT00706446","phase":"NA","title":"The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2008-06","conditions":"Asthma","enrollment":255},{"nctId":"NCT02725242","phase":"PHASE3","title":"Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma","status":"COMPLETED","sponsor":"Hat Yai Medical Education Center","startDate":"2016-03","conditions":"Asthma","enrollment":77},{"nctId":"NCT03073057","phase":"PHASE1","title":"Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler","status":"COMPLETED","sponsor":"Orion Corporation, Orion Pharma","startDate":"2016-01","conditions":"Asthma","enrollment":20},{"nctId":"NCT02811016","phase":"PHASE1","title":"Inhaled Budesonide and Acute Mountain Sickness","status":"COMPLETED","sponsor":"Salzburger Landeskliniken","startDate":"2016-06","conditions":"Acute Mountain Sickness","enrollment":51},{"nctId":"NCT01783821","phase":"PHASE2","title":"LIPS-B: Lung Injury Prevention Study With Budesonide and Beta","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-07","conditions":"Acute Respiratory Distress Syndrome (ARDS)","enrollment":61},{"nctId":"NCT01203904","phase":"","title":"Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-09","conditions":"Bronchial Asthma","enrollment":301},{"nctId":"NCT00395239","phase":"PHASE4","title":"Asthma/Steroid Withdrawal Study","status":"TERMINATED","sponsor":"University of Alberta","startDate":"2006-10","conditions":"Asthma","enrollment":6},{"nctId":"NCT01973751","phase":"NA","title":"Asthma Biomarkers for Predicting Response to Therapy","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2013-11","conditions":"Asthma","enrollment":148},{"nctId":"NCT02771717","phase":"PHASE4","title":"Low Exhaled NO and ICS in Suspected Asthma","status":"UNKNOWN","sponsor":"University of Nottingham","startDate":"2016-05","conditions":"Asthma","enrollment":165},{"nctId":"NCT00117182","phase":"PHASE2","title":"Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD","status":"COMPLETED","sponsor":"Syntara","startDate":"2005-07","conditions":"Lung Diseases, Obstructive","enrollment":140},{"nctId":"NCT01814618","phase":"PHASE2","title":"Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery","status":"WITHDRAWN","sponsor":"University of North Carolina, Chapel Hill","startDate":"2013-03","conditions":"Olfaction Disorders, Sinusitis, Paranasal Sinus Diseases","enrollment":""},{"nctId":"NCT00321893","phase":"PHASE2","title":"Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2006-01","conditions":"Lung Cancer","enrollment":225},{"nctId":"NCT00588406","phase":"PHASE3","title":"Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2007-09","conditions":"Asthma","enrollment":95},{"nctId":"NCT00728481","phase":"PHASE2, PHASE3","title":"The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-05","conditions":"Eosinophilic Esophagitis, Gastroesophageal Reflux Disease, EE","enrollment":51},{"nctId":"NCT02504801","phase":"PHASE4","title":"Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD","status":"UNKNOWN","sponsor":"Xiuyi Zhi","startDate":"2015-07","conditions":"Post Operative Complication, Pulmonary, Lung Cancer, COPD","enrollment":73},{"nctId":"NCT02308098","phase":"PHASE3","title":"To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product","status":"COMPLETED","sponsor":"Orion Corporation, Orion Pharma","startDate":"2014-12","conditions":"Asthma","enrollment":72},{"nctId":"NCT02165046","phase":"PHASE1","title":"Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.","status":"COMPLETED","sponsor":"Intech Biopharm Ltd.","startDate":"2012-02","conditions":"Asthma, Chronic Obstructive Pulmonary Disease (COPD)","enrollment":24},{"nctId":"NCT00294398","phase":"NA","title":"Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2006-03","conditions":"Asthma","enrollment":152},{"nctId":"NCT01225549","phase":"PHASE2","title":"The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-11","conditions":"Asthma","enrollment":27}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Pulmicort Turbuhaler","genericName":"Pulmicort Turbuhaler","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pulmicort (budesonide) is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue. Used for Asthma (maintenance and reliever therapy), Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}